Valeo Pharma Inc. Opens the Market
TORONTO, May 9, 2022 /CNW/ - Steve Saviuk, Chief Executive Officer, Frederic Fasano, President and Chief Operating Officer, Luc Mainville, Senior Vice-President and Chief Financial Officer, Valeo Pharma Inc. ("Valeo" or the "Company") (TSX: VPH) and their team joined Daniel Lubienietzky, Manager, Life Sciences, Toronto Stock Exchange, to celebrate the Company's new listing on Toronto Stock Exchange and open the market.
Headquartered in Kirkland, Quebec, Valeo Pharma is a Canadian specialty pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada, with a focus on respirology, neurodegenerative diseases, oncology and other specialty products.
Date: Monday, May 9, 2022
SOURCE Toronto Stock Exchange
Company Codes: Toronto:VPH
© 2022 PR Newswire. All Rights Reserved.